Empreendimentos Pague Menos (PGMN3) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
15 Jul, 2026Executive summary
Achieved record gross revenue of R$3.62 billion in 1Q25, up 17.1% year-over-year, driven by strong same-store sales growth and digital channel expansion.
Adjusted EBITDA rose 55.2% to R$150.3 million, with margin up 1 percentage point to 4.1%, reflecting operational leverage and cost control.
Adjusted net income reached R$13.1 million, reversing a loss in 1Q24, with margin improvement of 1.1 p.p.
Market share increased to 6.5% nationally, with gains in all regions and six consecutive quarters of share growth.
Digital channels revenue rose 53.6% to R$639 million, now 17.6% of total sales.
Financial highlights
Gross profit reached R$1,041.1 million, with margin at 28.7% of gross revenue, down 0.5 p.p. year-over-year.
Operating cash flow (LTM) hit a record R$487 million, up 16% year-over-year.
Net debt/Adjusted EBITDA improved to 1.9x from 2.8x in 1Q24.
Capex reached R$27.6 million, up 129% year-over-year, mainly for expansion and store refurbishments.
Cash operating cycle reduced to 50 days, 10 days shorter year-over-year, with significant inventory reduction.
Outlook and guidance
Minimum of 50 new store openings projected for 2025, with 7 opened in 1Q25.
Continued focus on operational efficiency, digital channel growth, and market share expansion.
Ongoing deleveraging and working capital improvements expected to support future profitability.
Strategic plan execution and integration of Extrafarma expected to drive further gains.
Latest events from Empreendimentos Pague Menos
- Revenue and profit surged as growth accelerated, cash flow improved, and market share increased.PGMN3
Q2 202415 Jul 2026 - Record sales, margin gains, and cash flow driven by Extrafarma synergies and digital growth.PGMN3
Q3 202415 Jul 2026 - Record sales and digital growth drove higher margins, profit, and market share gains.PGMN3
Q2 202515 Jul 2026 - Record 18% revenue growth, 49.6% net income rise, and 6.7% market share in 3Q25.PGMN3
Q3 202515 Jul 2026 - Revenue up 14.4% YoY, net income quadrupled, and digital sales surged to 22.2% of total.PGMN3
Q1 202615 Jul 2026 - 2025 saw record revenue, EBITDA, and net income, with market share and digital sales at all-time highs.PGMN3
Q4 20257 Jul 2026 - Record sales, margin expansion, and synergy gains drive robust growth and deleveraging.PGMN3
Q4 20242 Jul 2026 - Nationwide healthcare platform drives growth through digital innovation and health services expansion.PGMN3
Investor Presentation3 Jul 2025 - Nationwide Health Hub and digital innovation fuel PagueMenos extrafarma’s rapid, profitable growth.PGMN3
Investor Presentation16 Jun 2025